Results 141 to 150 of about 10,224,515 (204)

'It helps me stay on track': patient experiences using a mobile app for self-management of systemic sclerosis with a focus on fatigue in women. [PDF]

Rheumatol Adv Pract
Chen YT, Harper AE, Alore M, Haro E, Morris JT, Khanna D, Murphy SL.   +6 more
europepmc   +1 more source

High levels of vascular cell adhesion molecule-1 associate with a 'vasculopathic' phenotype in systemic sclerosis with higher mortality. [PDF]

Rheumatology (Oxford)
Parker MJS, Nikpour M, Hansen D, Hanson AL, Sahhar J, Brown MA, Corte TJ, Proudman S, Kenna TJ, Australian Scleroderma Interest Group.   +9 more
europepmc   +1 more source

Scleroderma: disease subtypes and multiorgan manifestations. [PDF]

Trends Mol Med
Johnson NM, Hinchcliff ME, Odell ID.
europepmc   +1 more source

Safety and Microvascular Effect of Four-Year Aminaphtone Administration in Systemic Sclerosis Patients. [PDF]

Open Access Rheumatol
Campitiello R, Sulli A, Hysa E, Pizzorni C, Cutolo M, Paolino S, Gotelli E.   +6 more
europepmc   +1 more source

A Hospitalized Patient With Systemic Scleroderma Requiring ICU-Level Care. [PDF]

Cureus
Ghahary D, Goldstein B, Hong L, Maffey M.   +3 more
europepmc   +1 more source

Prevalence and Clinical Associations of Systemic Sclerosis-Related Autoantibodies: A Nationwide Reuma.pt Cohort Study. [PDF]

Antibodies (Basel)
Mazeda C, Dourado E, Freitas R, Martins P, Saraiva L, Santiago T, Guimarães F, Costa E, Almeida DE, Dinis S, Pinto AS, Daniel A, Genrinho I, Couto M, Rodrigues M, Salvador MJ, Duarte AC, Cordeiro A, Santos MJ, Fonseca JE, Resende C, Cordeiro I.   +21 more
europepmc   +1 more source

Radiomic analysis of high-resolution computed tomography predicts interstitial lung disease progression and mortality in systemic sclerosis. [PDF]

Rheumatology (Oxford)
Iacovantuono M, Landini N, Jungblut L, Sauer GM, Käs F, Dobrota R, Muraru S, Elhai M, Mihai C, Becker MO, Chimenti MS, Frauenfelder T, Hoffmann-Vold AM, Distler O, Bruni C.   +14 more
europepmc   +1 more source

Scleroderma-Specific Autoantibodies and Disease Trajectories in Early Systemic Sclerosis: Insights From a Single-Center Prospective Registry. [PDF]

ACR Open Rheumatol
Jamali M, Kaur A, Huang S, Zahn C, Mulcaire-Jones E, Varga J, Khanna D.   +6 more
europepmc   +1 more source

Clinical and Dermoscopic Features of Pigmentary Changes in Scleroderma and Its Association with Systemic Involvement - A Descriptive Study from a Tertiary Care Centre in South India. [PDF]

Indian J Dermatol
Shijini N, Khader A, Keerankulangara D, Fathimathusalma O, Amrutha D.   +4 more
europepmc   +1 more source

Are we ready to predict progressive disease in juvenile systemic sclerosis? [PDF]

J Scleroderma Relat Disord
Foeldvari I, Klotsche J, Torok KS.
europepmc   +1 more source